Brief: Cipher Pharmaceuticals reports Q3 2016 financial results
11/11/2016 12:00
Nov 11 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO
* Q3 loss per share C$0.08 excluding items
* Q3 loss per share C$0.81
* Q3 revenue rose 10 percent to C$9.3 million
* Q3 revenue view $10.4 million -- Thomson Reuters I/B/E/S
* Cipher Pharmaceuticals reports Q3 2016 financial results
Source text for Eikon: ID:nCNW5htZQa
Further company coverage: CPH.TO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million